Using a paclitaxel-coated balloon to treat femoropopliteal artery disease results in better primary patency than does standard balloon angioplasty at 1 year and is associated with good safety outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback